Inventor
MALIK IBRAHIM JOHN
DK17 patents
Patents
17 patentsUS10800836B2Oct 13, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS10 citations92
US10647763B2May 12, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10647764B2May 12, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10640554B2May 5, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10364285B2Jul 30, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US10358483B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US10358482B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS11 citations92
US10358484B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US11542323B2Jan 3, 2023
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US11524995B2Dec 13, 2022
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US11421024B2Aug 23, 2022
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US10479835B2Nov 19, 2019
Agent, uses and methods for treatment
H LUNDBECK AS4 citations82
US10428147B2Oct 1, 2019
Anti-sortilin antibodies, uses and methods for treatment
H LUNDBECK AS4 citations82
US11548950B2Jan 10, 2023
Agent, uses and methods for treatment
H LUNDBECK AS1 citations71
US10889650B2Jan 12, 2021
Agent, uses and methods for treatment
H LUNDBECK AS2 citations71
US10894833B2Jan 19, 2021
Agents, uses and methods for treatment
H LUNDBECK AS2 citations70
US12331123B2Jun 17, 2025
Agent, uses and methods for treatment
H LUNDBECK AS0 citations61